Event Recordings

Day 1  |  Day 2

Day 2: Tuesday, April 20, 2021

Day 2 Welcome

Joseph Wu, MD, PhD, Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University

Session VI: COVID-19 Industry and Societal Shifts

Moderators: Andrew Plump, MD, PhD, and Julie Parsonnet, MD

The Clinical Trial Enterprise: Lessons from a Pandemic

Janet Woodcock, MD, Acting Commissioner, FDA

Learnings from the Development of the BNT162b2 mRNA COVID-19 Vaccine

Kathrin Jansen, PhD, Senior Vice President, Head of Vaccine Research and Development, Pfizer

COVID-19: It’s the End of the World as We Know it…

Anne Heatherington, PhD, Senior Vice President, Head of Data Sciences Institute, Takeda

Development of the Moderna COVID-19 Vaccine (mRNA-1273)

Andrea Carfi, PhD,Chief Scientific Officer for Infectious Disease at Moderna

Panel Discussion

Moderators: Andrew Plump, MD, PhD, and Julie Parsonnet, MD

Featuring:

Janet Woodcock, MD
Acting Commissioner, FDA

Andrea Carfi, PhD
Vice President and Head of Research, Infectious Disease, Moderna, Inc.

Kathrin Jansen, PhD
Senior Vice President, Head of Vaccine Research and Development, Pfizer

Anne Heatherington, PhD
Senior Vice President, Head of Data Sciences Institute, Takeda

Session VII: Stanford Drug Discovery Showcase

Moderators: Camille Samuels, MBA, and Sanjay Malhotra, PhD

The Cardiac Myosin Activator, Omecamtiv Mecarbil: From Concept to Clinic

Fady Malik, MD, PhD, Executive Vice President, Research and Development, Cytokinetics

Mastering Biology to Advance Human Health

Serge Saxonov, PhD, Co-Founder and CEO, 10X Genomics

Mir Imran, MS
Chairman and CEO
Rani Therapeutics

A Brief, Recent History of Drug Discovery in AAV Gene Therapy

Ken Mills, President and CEO, REGENXBIO

Panel Discussion

Moderators: Camille Samuels, MBA, and Sanjay Malhotra, PhD

Featuring:

Fady Malik, MD, PhD
Executive Vice President, Research and Development, Cytokinetics

Serge Saxonov, PhD
Co-Founder and CEO, 10X Genomics

Mir Imran, MS
Chairman and CEO, Rani Therapeutics

Ken Mills
President and CEO, REGENXBIO

Session VIII: Discovery Research II

Moderators: Marc Tessier-Lavigne, PhD, and Kuldev Singh, MD

The VelociSuite Platform for COVID-19 Antiviral Therapy

George Yancopoulos, MD, PhD,President & CSO, Regeneron

Creating Transformational Medicines

Mathai Mammen, MD, PhD, Global Head of Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson

Towards Personalized Healthcare in Therapeutic Development

Levi Garraway, MD, PhD, CMO, Genentech

Data Convergence and Innovation Medicine

Thomas Hudson, MD, Senior Vice President, R&D and Chief Scientific Officer, AbbVie

Panel Discussion

Moderators: Marc Tessier-Lavigne, PhD, and Kuldev Singh, MD

Featuring:

George Yancopoulos, MD, PhD
President & CSO, Regeneron

Joan Mannick, MD
Head of Research and Development, Life Biosciences

Mathai Mammen, MD, PhD
Global Head of Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson

Levi Garraway, MD, PhD
CMO, Genentech

Thomas Hudson, MD
Senior Vice President, R&D and Chief Scientific Officer, AbbVie

Session IX: Health Policy

Moderators: Lloyd Minor, MD, and Woodrow A. Myers, Jr., MD, MBA

Fireside Chat with Woodrow A. Myers, Jr., MD, MBA

Helene Gayle, MD, MPH, President & CEO, The Chicago Community Trust

Disruptive Innovation in Health Care: In Memory of Clayton Christensen

Mark Smith, MD, MBA, Founding President & CEO, California Healthcare Foundation

Drug Discovery and Bioinnovation: Opportunities and Challenges

Elias Zerhouni, MD, Former President for R&D, Sanofi; former Director of the NIH; former U.S. Presidential Science Envoy

The Post-COVID Crisis in CV Disease – Policy Implications for Drug Development and Lifecycle Management

Robert Califf, MD, Head of Strategy and Policy, Verily Life Sciences and Google Health Divisions of Alphabet

Panel Discussion

Moderators: Lloyd Minor, MD, and Woodrow A. Myers, Jr., MD, MBA

Featuring:

Helene Gayle, MD, MPH
President & CEO, The Chicago Community Trust

Mark Smith, MD, MBA
Founding President & CEO, California Healthcare Foundation

Elias Zerhouni, MD
Former President for R&D, Sanofi; former Director of the NIH; former U.S. Presidential Science Envoy

Robert Califf, MD
Head of Strategy and Policy, Verily Life Sciences and Google Health Divisions of Alphabet

Closing Remarks Day 2

Joseph Wu, MD, PhD, Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University